Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Headlines

Follow companies to personalize your feed

Today
Mitsubishi Electric Corp.Business
Mitsubishi Electric to Launch Railway Energy Management Solution Proof of Concept for Krakow Tram Network in Poland
37 minutes ago
Ascentage Pharma Grp InternationalBusiness
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
4 hours ago
Modular Medical IncBusiness
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
4 hours ago
Yesterday
Sbc Communications Inc.Business
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock
5 hours ago
Monopar Therapeutics IncBusiness
Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026
5 hours ago
Lg Innotek Co LtdBusiness
LG Innotek to Supply Cutting-Edge Automotive Wi-Fi 7 Communication Module to a leading European automotive parts company
5 hours ago
Whitehawk Therapeutics, Inc.Business
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
6 hours ago
Xenon Pharmaceuticals IncBusiness
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
6 hours ago
Sidus Space IncBusiness
Sidus Space Announces Pricing of $58.5 Million Registered Direct Offering of Class A Common Stock
7 hours ago
Ast Spacemobile IncBusiness
AST SpaceMobile Addresses Today’s Orbital Launch of BlueBird 7 on the New Glenn Launch Vehicle
10 hours ago
Revolution Medicines IncHealth
Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting
10 hours ago
Topbuild CorpBusiness
QXO to Acquire TopBuild for $17 Billion
11 hours ago
Molecular Partners AgBusiness
Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712
12 hours ago
Nektar TherapeuticsBusiness
Nektar to Hold Conference Call to Discuss 52-Week Topline Results from the 16-Week Extension Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on April 20, 2026
12 hours ago
Harmonic IncBusiness
Harmonic Enables DIRECTV to Reimagine Nationwide DTH Service
13 hours ago
10x Genomics IncBusiness
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
a day ago
Apr 18 2026
Pliant Therapeutics IncBusiness
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
a day ago
Zai Lab LtdBusiness
Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases
2 days ago
Argen-xHealth
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
2 days ago
Nexstar Broadcasting Group IncBusiness
Nexstar Media Group, Inc., Statement on Preliminary Injunction
2 days ago
Business
36m ago
Less than 1 min read

Mitsubishi Electric to Launch Railway Energy Management Solution Proof of Concept for Krakow Tram Network in Poland

Railway data analysis service and energy storage system for optimized electricity usage

TOKYO, April 20, 2026--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it will launch a proof of concept (PoC) project for a railway energy management solution (railway EMS) to be tested on the tram network in Krakow, Poland, beginning in April 2026. The project will combine Mitsubishi Electric’s SerendieTM digital platform and energy storage systems (ESSs) for the efficient capture and use of surplus regenerative braking power during tram operations.

Support for the project will be provided by Miejskie Przedsiębiorstwo Komunikacyjne S.A. w Krakowie (MPK), the public transport provider of the Krakow city; Zarząd Dróg Miasta Krakowa (ZDMK), the tram rail and road authority; and MEDCOM Sp. z o.o., Mitsubishi Electric’s capital partner company based in Poland.

Given Poland’s rapid economic growth and the resulting expectation of increased electricity demand, the recent surge in fuel prices has raised concerns about rising energy costs. Railway operators are striving to reduce power consumption, including during peak power spikes, as well as reduce carbon emissions, improve energy efficiency and stabilize the voltage supplied to railcars via overhead catenary systems.

For the full text, please visit: www.MitsubishiElectric.com/news/

View source version on businesswire.com: https://www.businesswire.com/news/home/20260419618629/en/

Contacts

Customer Inquiries
Mobility Infrastructure Systems Marketing Division
Public Utility Systems Group
Mitsubishi Electric Corporation
[email protected]
www.MitsubishiElectric.com/

Media Inquiries
Takeyoshi Komatsu
Public Relations Division
Mitsubishi Electric Corporation
Tel: +81-3-3218-2332
[email protected]
www.MitsubishiElectric.com/en/pr/

DISCLAIMER OF LIABILITY

6ix Inc. ("6ix") licenses software to publicly traded issuers of securities ("Issuers" and each an "Issuer") which can be used by Issuers to communicate with current and prospective investors ("Investors" and each an "Investor") on the online platform maintained by 6ix Inc. at www.6ix.com (the "Platform"). Each Issuer is solely responsible for all content relating to the Issuer on the 6ix Platform, including without limitation all investor summits presented by the Issuer and all summary information about the Issuer on the 6ix Platform.

All content provided on the 6ix Platform is for informational and educational purposes only and should not be construed as investment advice or an offer or solicitation in respect to any products or services. The content presented on the 6ix Platform should not be used as the basis for any investment decision, and does not purport to provide any legal, tax or accounting advice. There are inherent risks involved with investing in Issuers, as set out in the public disclosure record of each Issuer. Issuers are not responsible for revising or updating any information that they present on the 6ix Platform.

Investors should refer to the continuous disclosure documents filed by each Issuer under applicable securities laws, including risk factors and warnings regarding "forward looking information". Issuers are solely responsible for compliance with applicable securities laws, and 6ix makes no representations and provides no assurances to Investors regarding the accuracy or truthfulness of information presented by Issuers on the 6ix Platform or in their public disclosure records.

6ix is not licensed to trade, deal or advise in securities in any jurisdiction. 6ix does not recommend or endorse any Issuer on the 6ix Platform, nor does 6ix verify the accuracy of any information presented by Issuers to Investors on the 6ix Platform or in their public disclosure records. 6ix's sole responsibility as the operator of the 6ix Platform is to provide software to Issuers and Investors through which Issuers and Investors communicate directly with each other without any intermediation or intervention by 6ix other than in respect of technical, logistical or advertising and marketing support. Issuers pay 6ix a licensing fee for use of the 6ix Platform, and 6ix may also receive payment from Issuers to pay for advertising on third-party websites. 6ix and its principals may make and hold investments in securities of Issuers on the 6ix Platform and 6ix may offer reduced rates for its software services to Issuers in which 6ix and/or its principals are invested.

ALL CONTENT ON THE PLATFORM IS PROVIDED BY THE ISSUERS "AS IS" AND "AS AVAILABLE". 6IX DOES NOT GUARANTEE THE ACCURACY OF ITS CONTENT. BY USING THE PLATFORM, EACH INVESTOR AGREES TO ACCEPT ANY RISKS ASSOCIATED WITH THE USE OF THE PLATFORM AND ACKNOWLEDGES THAT 6IX IS NOT RESPONSIBLE FOR ANY CONTENT PRESENTED BY OR RELATING TO ISSUERS ON THE PLATFORM.

6IX DOES NOT WARRANT THAT THE PROVISION OF INFORMATION BY ISSUERS ON THE PLATFORM WILL BE ERROR-FREE, TIMELY, COMPLETE OR ACCURATE. USE OF THE PLATFORM AND RELIANCE THEREON IS AT INVESTOR'S SOLE RISK. 6IX WILL NOT BE IN ANY WAY BE LIABLE TO ANY INVESTOR OR ISSUER OR ANY OTHER ENTITY OR PERSON FOR ANY INACCURACIES, ERRORS, OMISSIONS, DELAYS, DAMAGES, CLAIMS, LIABILITIES OR LOSSES, REGARDLESS OF CAUSE, IN OR ARISING FROM THE USE OF THE PLATFORM.

IN NO EVENT WILL 6IX BE LIABLE FOR ANY DAMAGES, INCLUDING WITHOUT LIMITATION DIRECT OR INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, LOSSES OR EXPENSES ARISING IN CONNECTION WITH THE USE OF THE PLATFORM BY INVESTORS AND/OR ISSUERS EVEN IF 6IX IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, LOSSES OR EXPENSES. FURTHER, 6IX SHALL NOT BE LIABLE IN ANY MANNER FOR THE PRODUCT OR SERVICES OF ANYONE WHO REDISTRIBUTES THE INFORMATION PROVIDED ON THE PLATFORM, AND SUCH REDISTRIBUTION IS EXPRESSLY PROHIBITED.